FDA Inspection 971471 — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on May 13, 2016 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 13, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)